Fluxion Biosciences, a leading provider of functional cell biology
systems for life science research and drug discovery, today announced
that it has won a 2008 R&D 100 Award for its BioFlux™
200 System. The R&D 100 Award places the state-of-the-art BioFlux System
in the prestigious company of previous winners such as liquid crystal
displays and the anticancer drug Taxol.
Known as "the Oscars of Invention," the R&D 100 Award showcases the most
significant new technologies commercialized worldwide. This year, R&D
Magazine recognized Fluxion for a combination of research and
manufacturing excellence in developing the BioFlux System. Based on
novel microfluidics and flow control technology, the BioFlux System
helps researchers understand disease processes and identify therapeutics
in such areas as cardiovascular disease, immune disorders, stem cell
research, and infectious diseases.
The BioFlux System integrates the ease of use of standard well plates
with the biological relevance of a flow-based assay. The system enables
functional live-cell assays in a high throughput format, delivering
physiologically relevant data much earlier in the drug discovery process
than is possible with conventional approaches. The system is used
routinely to study cellular interactions, including cell adhesion,
transmigration, and biofilm formation. Introduced in 2007, the BioFlux
system is used globally by leading pharmaceutical companies and research
institutes including the University of California at San Francisco,
Lawrence Berkeley National Lab, Stanford University, Kimberly Clark,
University of London, and the National Institutes of Health.
"We are honored to be recognized by R&D Magazine for our new
microfluidics technology and to be ranked among the world's top
technology innovators," said Mike Schwartz, BioFlux Program Director.
"The BioFlux System is an example of Fluxion’s
strength as a leading technology developer for the life sciences
industry. It's gratifying to see recognition of our commitment to
provide enabling products and technologies that improve the research
activities of our life science customers worldwide."
About Fluxion Biosciences
Fluxion Biosciences provides cellular analysis tools for use in critical
life science research and drug discovery applications. Fluxion’s
proprietary microfluidic platform enables precise functional analysis of
individual cells in a multiplexed format. Products include the BioFlux™
system for studying cellular interactions, and the IonFlux™
system for high throughput ion channel screening. Fluxion’s
systems meet the rigorous demands of life science and drug discovery
scientists by providing an intuitive, easy-to-use operating system for
single-cell biology. For more information about Fluxion Biosciences,
visit www.fluxionbio.com.
|